NewsFlash Daily™
Precision robotic surgery cures a rare pancreatic condition in a newborn, doctors avert life-threatening hypoglycemia and long-term complications
Bengaluru: In a remarkable medical breakthrough, a 16-day-old newborn suffering from the rare condition Congenital Hyperinsulinism was successfully treated through advanced robotic surgery at Manipal Hospital, Whitefield. The life-saving intervention prevented the infant from facing permanent brain damage caused by severe and recurrent hypoglycemia.
Newborn at High Risk of Brain Damage
The baby, weighing 4.6 kg at birth, was experiencing dangerously low blood sugar levels despite being administered high doses of intravenous glucose. Doctors observed that the infant’s glucose levels were dropping rapidly, putting the child at immediate risk of neurological damage.
Rare Condition Diagnosed in Time
After intensive evaluation, specialists identified a small focal lesion in the pancreas responsible for producing excessive insulin. This rare disorder, known as Congenital Hyperinsulinism, can lead to critical complications if not treated promptly.
Targeted Surgery Saves Pancreas
Unlike conventional treatment methods that may require removal of a large portion or the entire pancreas, doctors opted for a targeted surgical approach. Since the abnormality was confined to a specific area, surgeons were able to remove only the affected portion, significantly reducing the risk of long-term side effects such as diabetes.
Why Robotic Surgery Was Chosen
Given the extremely delicate age of the patient and the complexity of the condition, the medical team chose robotic-assisted surgery to ensure precision.
“Robotic surgery allowed us to precisely target the lesion without damaging surrounding tissues. The procedure was completed without bleeding or complications,” hospital sources stated.
The advanced technique enabled surgeons to operate with high accuracy and minimal invasion, which is crucial in neonatal cases.
Successful Outcome, Baby Recovers Fully
Following the surgery, the baby’s blood sugar levels normalised immediately, eliminating the need for further glucose support. The infant was closely monitored in the Neonatal Intensive Care Unit (NICU) for nine days before being discharged in stable condition.
Doctors confirmed that the child is now healthy and free from the condition, marking a significant success in pediatric surgical care.
Breakthrough Raises Hope for Rare Pediatric Disorders
This case highlights the growing role of robotic technology in neonatal surgeries, offering safer and more effective treatment options for rare and life-threatening conditions. Medical experts believe such advancements could transform outcomes for infants diagnosed with complex disorders at an early stage.
